Burzynski Research Institute's quarterly market cap
declined
from May. 2023 ($7.91 Mil) to Aug. 2023 ($6.35 Mil) and
declined
from Aug. 2023 ($6.35 Mil) to Nov. 2023 ($5.53 Mil).
Burzynski Research Institute's annual market cap
increased
from Feb. 2021 ($3.81 Mil) to Feb. 2022 ($3.94 Mil) and
increased
from Feb. 2022 ($3.94 Mil) to Feb. 2023 ($4.83 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Burzynski Research Institute's Enterprise Value for Today is $5.62 Mil.
Burzynski Research Institute Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Burzynski Research Institute's Market Cap
For the Biotechnology subindustry, Burzynski Research Institute's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Burzynski Research Institute's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's Market Cap distribution charts can be found below:
* The bar in red indicates where Burzynski Research Institute's Market Cap falls into.
Burzynski Research Institute Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Burzynski Research Institute (OTCPK:BZYR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Burzynski Research Institute Market Cap Related Terms
Thank you for viewing the detailed overview of Burzynski Research Institute's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Burzynski Research Institute (Burzynski Research Institute) Business Description
Burzynski Research Institute Inc engages in the research, production, marketing, promotion, and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. Antineoplastons are used in the treatment of human cancer. Its pipeline development programs of the company include clinical trials for the treatment of a wide variety of cancers using only a combination of Antineoplastons A10 and AS2-1.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BZYR has been successfully added to your 